Sage E - Search Results

1

Primed infusion with delayed equilibrium of Gd.DTPA for enhanced imaging of small pulmonary metastases.

Kalber TL, Campbell-Washburn AE, Siow BM, Sage E, Price AN, Ordidge KL, Walker-Samuel S, Janes SM, Lythgoe MF. Kalber TL, et al. Among authors: sage e. PLoS One. 2013;8(1):e54903. doi: 10.1371/journal.pone.0054903. Epub 2013 Jan 31. PLoS One. 2013. PMID: 23382996 Free PMC article.

2

Mesenchymal stem cells as vectors for lung disease.

Loebinger MR, Sage EK, Janes SM. Loebinger MR, et al. Proc Am Thorac Soc. 2008 Aug 15;5(6):711-6. doi: 10.1513/pats.200801-009AW. Proc Am Thorac Soc. 2008. PMID: 18684723 Free PMC article. Review.

3

TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population.

Loebinger MR, Sage EK, Davies D, Janes SM. Loebinger MR, et al. Among authors: sage ek. Br J Cancer. 2010 Nov 23;103(11):1692-7. doi: 10.1038/sj.bjc.6605952. Epub 2010 Nov 9. Br J Cancer. 2010. PMID: 21063402 Free PMC article.

4

β-Catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial-mesenchymal transition.

Giangreco A, Lu L, Vickers C, Teixeira VH, Groot KR, Butler CR, Ilieva EV, George PJ, Nicholson AG, Sage EK, Watt FM, Janes SM. Giangreco A, et al. J Pathol. 2012 Mar;226(4):575-87. doi: 10.1002/path.3962. Epub 2012 Jan 17. J Pathol. 2012. PMID: 22081448 Free PMC article.

5

Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ.

Reagan MR, Seib FP, McMillin DW, Sage EK, Mitsiades CS, Janes SM, Ghobrial IM, Kaplan DL. Reagan MR, et al. J Breast Cancer. 2012 Sep;15(3):273-82. doi: 10.4048/jbc.2012.15.3.273. Epub 2012 Sep 28. J Breast Cancer. 2012. PMID: 23091539 Free PMC article.

6

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma.

Sage EK, Kolluri KK, McNulty K, Lourenco Sda S, Kalber TL, Ordidge KL, Davies D, Gary Lee YC, Giangreco A, Janes SM. Sage EK, et al. Thorax. 2014 Jul;69(7):638-47. doi: 10.1136/thoraxjnl-2013-204110. Epub 2014 Feb 24. Thorax. 2014. PMID: 24567297 Free PMC article.

7

Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.

Lathrop MJ, Sage EK, Macura SL, Brooks EM, Cruz F, Bonenfant NR, Sokocevic D, MacPherson MB, Beuschel SL, Dunaway CW, Shukla A, Janes SM, Steele C, Mossman BT, Weiss DJ. Lathrop MJ, et al. Among authors: sage ek. Cancer Gene Ther. 2015 Jan;22(1):44-54. doi: 10.1038/cgt.2014.68. Epub 2014 Dec 19. Cancer Gene Ther. 2015. PMID: 25525034

8

Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy.

Yuan Z, Kolluri KK, Sage EK, Gowers KH, Janes SM. Yuan Z, et al. Cytotherapy. 2015 Jul;17(7):885-96. doi: 10.1016/j.jcyt.2015.03.603. Epub 2015 Apr 14. Cytotherapy. 2015. PMID: 25888191 Free PMC article.

9

CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity.

Vallath S, Sage EK, Kolluri KK, Lourenco SN, Teixeira VS, Chimalapati S, George PJ, Janes SM, Giangreco A. Vallath S, et al. Sci Rep. 2016 Apr 1;6:24006. doi: 10.1038/srep24006. Sci Rep. 2016. PMID: 27035095 Free PMC article.

10

Combined cell-gene therapy for lung cancer: rationale, challenges and prospects.

Thakrar RM, Sage EK, Janes SM. Thakrar RM, et al. Expert Opin Biol Ther. 2016 Jul;16(7):853-7. doi: 10.1080/14712598.2016.1188074. Epub 2016 Jun 3. Expert Opin Biol Ther. 2016. PMID: 27248673 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters